Document is current
Any future updates will be listed below
-
Authors
Hindelang, Michael https://orcid.org/0000-0003-2856-8645
Klimova, Daria
Domenech, Arnau
Kasujee, Ismail
Biedermann, Tilo
Zink, Alexander
-
Funding
Funding for this research was provided by:
Almirall
- License Information
-
More Information
Article History
Received: 12 September 2025
Accepted: 20 February 2026
First Online: 19 March 2026
Declarations
:
: Michael Hindelang is currently employed by Johnson & Johnson Innovative Medicine. This employment began after completion of the study and preparation of the manuscript; the work reported here was conducted while he was affiliated with the Technical University of Munich. Daria Klimova, Tilo Biedermann, and Alexander Zink declare no competing interests. Arnau Domenech and Ismail Kasujee are employees of Almirall S.A., which funded the study and was involved in its conceptual design.
: The study was reviewed and approved by the Ethics Committee of the Faculty of Medicine at the Technical University of Munich (2024-472-S-SB) and was conducted in accordance with national law and the Declaration of Helsinki. Written informed consent was obtained from all participants prior to participation.
